TORRID HOLDINGS INC (CURV) Fundamental Analysis & Valuation

NYSE:CURV • US89142B1070

1.11 USD
-0.02 (-1.77%)
Last: Mar 5, 2026, 09:35 AM

This CURV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

CURV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. CURV has a medium profitability rating, but doesn't score so well on its financial health evaluation. CURV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. CURV Profitability Analysis

1.1 Basic Checks

  • In the past year CURV has reported negative net income.
  • In the past year CURV had a positive cash flow from operations.
  • CURV had positive earnings in 4 of the past 5 years.
  • In the past 5 years CURV always reported a positive cash flow from operatings.
CURV Yearly Net Income VS EBIT VS OCF VS FCFCURV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

1.2 Ratios

  • With a Return On Assets value of -0.47%, CURV perfoms like the industry average, outperforming 45.53% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 11.08%, CURV is doing good in the industry, outperforming 78.86% of the companies in the same industry.
  • CURV had an Average Return On Invested Capital over the past 3 years of 19.24%. This is significantly above the industry average of 13.62%.
  • The 3 year average ROIC (19.24%) for CURV is well above the current ROIC(11.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.47%
ROE N/A
ROIC 11.08%
ROA(3y)5.1%
ROA(5y)2.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.24%
ROIC(5y)15.7%
CURV Yearly ROA, ROE, ROICCURV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

1.3 Margins

  • In the last couple of years the Profit Margin of CURV has declined.
  • CURV's Operating Margin of 2.87% is in line compared to the rest of the industry. CURV outperforms 55.28% of its industry peers.
  • In the last couple of years the Operating Margin of CURV has declined.
  • CURV has a Gross Margin (35.57%) which is comparable to the rest of the industry.
  • CURV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.87%
PM (TTM) N/A
GM 35.57%
OM growth 3Y13.99%
OM growth 5Y-6.94%
PM growth 3YN/A
PM growth 5Y-18.22%
GM growth 3Y-3.3%
GM growth 5Y-0.39%
CURV Yearly Profit, Operating, Gross MarginsCURV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1

2. CURV Health Analysis

2.1 Basic Checks

  • CURV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, CURV has more shares outstanding
  • The number of shares outstanding for CURV has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CURV has an improved debt to assets ratio.
CURV Yearly Shares OutstandingCURV Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CURV Yearly Total Debt VS Total AssetsCURV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.66, we must say that CURV is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of CURV (1.66) is worse than 60.98% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.66
ROIC/WACC1.11
WACC10%
CURV Yearly LT Debt VS Equity VS FCFCURV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M -200M 300M

2.3 Liquidity

  • CURV has a Current Ratio of 0.81. This is a bad value and indicates that CURV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.81, CURV is doing worse than 84.55% of the companies in the same industry.
  • A Quick Ratio of 0.26 indicates that CURV may have some problems paying its short term obligations.
  • The Quick ratio of CURV (0.26) is worse than 79.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.26
CURV Yearly Current Assets VS Current LiabilitesCURV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. CURV Growth Analysis

3.1 Past

  • The earnings per share for CURV have decreased strongly by -106.67% in the last year.
  • The earnings per share for CURV have been decreasing by -16.48% on average. This is quite bad
  • The Revenue has decreased by -7.33% in the past year.
  • CURV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.26% yearly.
EPS 1Y (TTM)-106.67%
EPS 3YN/A
EPS 5Y-16.48%
EPS Q2Q%-500%
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y-5.24%
Revenue growth 5Y1.26%
Sales Q2Q%-10.85%

3.2 Future

  • CURV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -28.61% yearly.
  • Based on estimates for the next years, CURV will show a decrease in Revenue. The Revenue will decrease by -5.03% on average per year.
EPS Next Y-173.31%
EPS Next 2Y-49.81%
EPS Next 3Y-28.61%
EPS Next 5YN/A
Revenue Next Year-9.37%
Revenue Next 2Y-7.26%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CURV Yearly Revenue VS EstimatesCURV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
CURV Yearly EPS VS EstimatesCURV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

1

4. CURV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CURV. In the last year negative earnings were reported.
  • Also next year CURV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CURV Price Earnings VS Forward Price EarningsCURV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CURV indicates a somewhat cheap valuation: CURV is cheaper than 60.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.14
CURV Per share dataCURV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

  • A cheap valuation may be justified as CURV's earnings are expected to decrease with -28.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-49.81%
EPS Next 3Y-28.61%

0

5. CURV Dividend Analysis

5.1 Amount

  • CURV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CURV Fundamentals: All Metrics, Ratios and Statistics

TORRID HOLDINGS INC

NYSE:CURV (3/5/2026, 9:35:08 AM)

1.11

-0.02 (-1.77%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-03
Earnings (Next)06-03
Inst Owners26.37%
Inst Owner Change-2.26%
Ins Owners7.44%
Ins Owner Change-0.07%
Market Cap110.11M
Revenue(TTM)1.04B
Net Income(TTM)-1.91M
Analysts52.73
Price Target1.5 (35.14%)
Short Float %12.35%
Short Ratio10.65
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-410%
Min EPS beat(2)-781.91%
Max EPS beat(2)-38.09%
EPS beat(4)2
Avg EPS beat(4)-186.62%
Min EPS beat(4)-781.91%
Max EPS beat(4)50.98%
EPS beat(8)5
Avg EPS beat(8)-95.97%
EPS beat(12)7
Avg EPS beat(12)-61.26%
EPS beat(16)9
Avg EPS beat(16)-48.04%
Revenue beat(2)1
Avg Revenue beat(2)-0.94%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.08%
Revenue beat(8)3
Avg Revenue beat(8)-1.53%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)8
Avg Revenue beat(16)0.59%
PT rev (1m)0%
PT rev (3m)-45.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-446.81%
EPS NY rev (1m)0%
EPS NY rev (3m)-268.3%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-8.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF 22.46
P/B N/A
P/tB N/A
EV/EBITDA 10.14
EPS(TTM)-0.01
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.05
OCFY4.45%
SpS10.48
BVpS-2.08
TBVpS-2.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.47%
ROE N/A
ROCE 17.54%
ROIC 11.08%
ROICexc 12.19%
ROICexgc 12.82%
OM 2.87%
PM (TTM) N/A
GM 35.57%
FCFM N/A
ROA(3y)5.1%
ROA(5y)2.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.24%
ROIC(5y)15.7%
ROICexc(3y)21.41%
ROICexc(5y)18.14%
ROICexgc(3y)22.22%
ROICexgc(5y)18.8%
ROCE(3y)29.27%
ROCE(5y)23.72%
ROICexgc growth 3Y22.64%
ROICexgc growth 5Y12.07%
ROICexc growth 3Y22.04%
ROICexc growth 5Y11.47%
OM growth 3Y13.99%
OM growth 5Y-6.94%
PM growth 3YN/A
PM growth 5Y-18.22%
GM growth 3Y-3.3%
GM growth 5Y-0.39%
F-Score3
Asset Turnover2.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 7.61
Cap/Depr 106.1%
Cap/Sales 0.69%
Interest Coverage 0.96
Cash Conversion 13.38%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.26
Altman-Z 1.66
F-Score3
WACC10%
ROIC/WACC1.11
Cap/Depr(3y)56.43%
Cap/Depr(5y)50.16%
Cap/Sales(3y)1.79%
Cap/Sales(5y)1.58%
Profit Quality(3y)196.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-106.67%
EPS 3YN/A
EPS 5Y-16.48%
EPS Q2Q%-500%
EPS Next Y-173.31%
EPS Next 2Y-49.81%
EPS Next 3Y-28.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.33%
Revenue growth 3Y-5.24%
Revenue growth 5Y1.26%
Sales Q2Q%-10.85%
Revenue Next Year-9.37%
Revenue Next 2Y-7.26%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A
EBIT growth 1Y-48.35%
EBIT growth 3Y8.01%
EBIT growth 5Y-5.77%
EBIT Next Year11.94%
EBIT Next 3Y15.38%
EBIT Next 5YN/A
FCF growth 1Y-119.8%
FCF growth 3Y-15.28%
FCF growth 5Y-2.85%
OCF growth 1Y-85.2%
OCF growth 3Y-13.89%
OCF growth 5Y-4.83%

TORRID HOLDINGS INC / CURV FAQ

What is the fundamental rating for CURV stock?

ChartMill assigns a fundamental rating of 2 / 10 to CURV.


What is the valuation status for CURV stock?

ChartMill assigns a valuation rating of 1 / 10 to TORRID HOLDINGS INC (CURV). This can be considered as Overvalued.


Can you provide the profitability details for TORRID HOLDINGS INC?

TORRID HOLDINGS INC (CURV) has a profitability rating of 4 / 10.


How financially healthy is TORRID HOLDINGS INC?

The financial health rating of TORRID HOLDINGS INC (CURV) is 1 / 10.